Caligiuri, Maureen <br/><br/>
A proteome-wide CDK/CRK-specific kinase inhibitor promotes tumor cell death in the absence of cell cycle progression.  [electronic resource] 

 -  Chemistry & biology  Oct 2005 
 - 1103-15 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1074-5521 
<br/><br/><label>Standard No.: </label>10.1016/j.chembiol.2005.08.008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Cell Cycle<br/>Cell Line, Tumor<br/>Cyclin-Dependent Kinases--antagonists & inhibitors<br/>Drug Screening Assays, Antitumor<br/>HCT116 Cells<br/>Humans<br/>Intracellular Signaling Peptides and Proteins--classification<br/>Proteome--drug effects<br/>Pyrimidines--classification